NCCN Guidelines® vs TNM Cancer Staging System Usage & Stats

The National Comprehensive Cancer Network® (NCCN®), is pleased to present the Virtual Library of NCCN Guidelines® app formatted for Smart Phones & Tablet. This easy-to-use and convenient format will further assist health care professionals in their implementation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), thus improving the quality and effectiveness of care provided to patients with cancer. NCCN is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world. Over the past 25 years, NCCN has developed an integrated suite of tools to improve the quality of cancer care. The NCCN Guidelines® document evidence-based, consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive services that are most likely to lead to optimal outcomes. The NCCN Guidelines are a comprehensive set of guidelines detailing the sequential management decisions and interventions that apply to 97 percent of cancer cases in the United States. In addition, separate guidelines relate to major prevention and screening topics and another set of pathways focuses on the major supportive care areas. The NCCN Guidelines provide recommendations based on the best evidence available at the time they are derived. Because new data are published continuously, it is essential that the NCCN Guidelines also be continuously updated and revised to reflect new data and new clinical information. The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care—including physicians, nurses, pharmacists, payers, patients and their families—with the ultimate goal of improving patient care and outcomes. The NCCN Guidelines provide recommendations for appropriate care for most but not all patients; however, individual patient circumstances must be considered when applying these recommendations. Visit NCCN.org to learn more about the NCCN Guidelines as well as other NCCN Content.

Google Play Store
Free
Medical

Store Rank

- -

TNM Cancer Staging System

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. TNM Cancer Staging System remains the gold standard reference for oncologists, surgeons, pathologists, radiologists, cancer registrars, & medical professionals worldwide to ensure that all those caring for cancer patients are fully versed in the language of cancer staging. This mobile resource includes Interactive TNM calculators that help proper classification and staging of cancer. *Breast cancer *Colon and Rectum *Distal Bile Duct *Liver *Neuroendocrine Tumors *Perihilar Bile Ducts *Stomach + Many others The TNM Cancer Staging System by AJCC is used by physicians & healthcare professionals throughout the world to facilitate the uniform description & reporting of neoplastic diseases. Proper classification and staging of cancer are essential for the physician to assign proper treatment, evaluate results of management and clinical trials, & serve as the standard for local, regional & international reporting on cancer incidence & outcome. Significantly expanded and developed by international disease site expert panels, this edition features 12 entirely new staging systems, a wide range of changed or new staging definitions, & a refined emphasis on a personalized-medicine approach. UPDATED CONTENT - General staging rules for clinical & pathological classifications - Staging systems in several chapters - Organization of T, N, M, and any additional categories into groups - Histologic classifications & grading systems - WHO histology codes - More illustrations - Extensive update to Version 9 Protocols of * Anus * Appendix * Brain and Spinal Cord * Cervix Uteri * NET Appendix, Colon & Rectum, Duodenum and Ampulla of Vater, Jejunum and Ileum, Pancreas, Stomach * Vulva NEW PARADIGMS - Human papillomavirus (HPV): oropharyngeal carcinoma staging systems based on HPV status - Separate staging systems for patients with neoadjuvant therapy (esophagus and stomach) NEW FEATURES - Levels of evidence provided for revisions to staging systems - Imaging section - Risk Assessment Models for select cancer sites - Recommendations for Clinical Trial Stratification - Prognostic factors - Required for prognostic stage grouping - Recommended for clinical care - Emerging factors NEW TOPICS/STAGING SYSTEMS - Risk Assessment Models - Cervical Nodes and Unknown Primary Tumors of the Head & Neck - Oropharynx, HPV-Mediated (p16+) - Cutaneous Carcinoma of the Head & Neck (includes cutaneous carcinoma of external lip) - Thymus - Bone: Appendicular Skeleton/Trunk/Skull/Face, Pelvis, & Spine - Soft Tissue Sarcoma of the Head & Neck, Trunk & Extremities, Abdomen & Thoracic Visceral Organs, Retroperitoneum, Unusual Histologies and Sites - Parathyroid - Leukemia Content licensed from printed ISBN 10: 3319406175 Content licensed from printed ISBN 13: 9783319406176 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $79.99 Payment will be charged to your mode of payment you select at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your App “Settings” and tapping “Manage Subscriptions”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): Mahul B. Amin, MD, FCAP (Editor-in-Chief), Stephen B. Edge, MD, FACS, Frederick L. Greene, MD, FACS, et. al. Publisher: Springer-Verlag New York, Inc.